StockData
MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics (MLTX) stock

MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$11.25−0.48 (-4.09%)

Close on Nov 17, 2026Market cap $957.45MP/E –Yield –

MoonLake Immunotherapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

MoonLake Immunotherapeutics's market cap was $933.97M on Nov 11, 2026, against $868.28M a year earlier. Over the last 5 years it ranged from $28.38M to $4.00B, with a median of $1.93B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$933.97M+12.1%
2025Dec 31, 2025$833.50M-75.2%
2024Dec 31, 2024$3.36B+26.4%
2023Dec 29, 2023$2.66B+958.2%
2022Dec 30, 2022$251.45M+784.4%
2021Dec 31, 2021$28.43M–

More MoonLake Immunotherapeutics figures

See a number that looks wrong?